Acute Generalized Exanthematous Pustulosis ... emphasizes the importance of recognizing this condition as a serious drug reaction that requires prompt identification and management.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but ... calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) ...